According to a report, scientists in the UK are developing a single vaccine to fight COVID-19 and common cold. The vaccine is expected to fight against various coronavirus variants which have led to virus waves across the world leading to shutdowns and increased deaths.

UK scientists eye single jab to tackle all coronavirus variants

US manufacturer Moderna has begun studying its coronavirus vaccine in children aged six months to 12 years old as the company informed that it plans to enroll children in the US and Canada for the trial.

Moderna to begin coronavirus vaccine trials on children in US and Canada

A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the Pfizer Inc-BioNTech SE vaccine by two-thirds, and it is not clear if the shot will be effective against the mutation, the companies said on Wednesday.

South African variant could reduce vaccine protection: Pfizer

The World Health Organization(WHO) granted two versions of the AstraZeneca-Oxford COVID-19 vaccine for emergency use produced by AstraZeneca-SKBio(Republic of Korea) and the Serum Institute of India(SII).

WHO gives emergency use approval to Serum Institute of India's AstraZeneca vaccine

Faced with the daunting task of parcelling out a limited supply of coronavirus vaccines, Trump administration officials came up with a seemingly simple formula last year to streamline distribution of the shots.

Where do vaccine doses go, and who gets them? The algorithms decide

The Republic of Palau with a population of around 18,000 located in western Pacific Ocean which hasn't recorded a single case of coronavirus was one of the first countries to be vaccinated against the virus.

Virus-free Palau located in Pacific could become first country to be vaccinated against COVID-19

Spain reported the first cases of new virus strain which emerged from Britain even as the country received the Pfizer-BioNTech vaccine. Watch: The regional government informed that all four cases of new coronavirus variant were detected in Madrid.

Spain confirms new virus strain as vaccines begin arriving in European nations

The interim findings of phase 1 clinical trial of COVID-19 vaccine Covaxin, indigenously developed by Bharat Biotech in collaboration with the ICMR, showed that it was was well tolerated in all dose groups with no serious or adverse events.

Bharat Biotech's phase 1 trial findings show COVID-19 vaccine well tolerated; no serious adverse events

The possibility of an adverse event after being vaccinated for COVID-19 cannot be ruled out, the government said on Tuesday and asked states and Union Territories to be prepared for this as part of the anti-coronavirus inoculation drive.

Possibility of adverse event after COVID-19 vaccination can't be ruled out: Government

After Margaret Keenan, 90, received the first shot of the Pfizer-BioNTech coronavirus vaccine in the UK, it was followed by an elderly man called William Shakespeare who like the famous British playwright also hails from Warwickshire.

'Not a joke': William Shakespeare from Warwickshire gets coronavirus jab in UK after Margaret Keenan

After the UK government approved the Pfizer-BioNTech's coronavirus vaccine, German firm BioNTech said it has taken steps to accelerate the process together with authorities without shortcuts.

Took steps to accelerate COVID-19 vaccine process without shortcuts: German firm BioNTech

The race for a coronavirus vaccine has stoked a debate on how much the jabs will cost and who will pay for them, as prices range from $10 to $40 per person. An affordable price for the coronavirus vaccine can very well act as the deciding factor in the purchase and sale of a particular brand and its profit.

Coronavirus vaccine: How price plays an extremely crucial role

US pharma company Pfizer said today that its experimental coronavirus vaccine showed that it is "95 per cent effective". Watch: Pfizer CEO Albert Bourla said: "The study results mark an important step in this historic eight-month journey to bring forward a vaccine capable of helping to end this devastating pandemic.

Final results show coronavirus vaccine 95% effective, says Pfizer

Amid "encouraging" news about a probable vaccine, European Central Bank president Christine Lagarde said that there would be "unsteady" eurozone recovery in times ahead.

EU president warns 'recurring cycles' viral spread despite vaccine

US corporation Pfizer said today that it would be conducting coronavirus vaccine trial which will include adolescents as young as 12. Also Read: World Bank approves $12 billion for COVID-19 vaccines Pfizer's Rod MacKenzie in a tweet said that the move has been approved by the US Food and Drug Association(FDA).

Pfizer to start coronavirus vaccine tests on children as young as 12

A mass roll-out of a COVID-19 vaccine in Britain could be finished in as little as three months, the Times reported, citing government scientists. Also Read: Russian state journalists among first to receive Sputnik V vaccine Scientists working on the Oxford vaccine hope regulators approve it before the beginning of 2021, the newspaper said.

Coronavirus vaccine rollout expected in less than 3 months in UK: Report

The world is desperate for a vaccine for the Wuhan virus and there is not one yet but Chinese citizens are set to get a jab. First, the workers of state-owned companies will receive a jab, teachers, supermarket employees and more will also get a shot.

How China's unapproved COVID-19 vaccine drive is putting citizens at risk

Coronavirus which is killing and infecting people all over the world was created in a Lab in China's Wuhan, such an idea would have been labelled a conspiracy theory until a few weeks ago.

COVID-19 was created in the Wuhan laboratory: Professor Giuseppe Tritto

According to Britain's Financial Times, volunteers in the UK will be infected with coronavirus in order to test a possible vaccine to combat the virus. Watch: The Boris Johnson government has reportedly been discussing the possibility of "human challenge studies" to develop the vaccine.

'Human challenge studies': UK may infect volunteers with coronavirus to test vaccine

The vaccines are being used at home and China is even selling them abroad. The Philippines will have quick access to Chinese coronavirus vaccine. China has also been offering loans for vaccines which is a whole new chapter in its debt diplomacy.

Now, China targets South China Sea rivals with vaccine diplomacy

Russia's sovereign wealth fund said on Wednesday it will supply India's Dr. Reddy's Laboratories with 100 million doses of the Sputnik-V vaccine against COVID-19 once it receives regulatory approval in India.

Russia to sell COVID-19 vaccine to Indian firm after regulatory approval

US drugmaker Pfizer's chief Albert Bourla on Sunday said it is ''likely'' the coronavirus vaccine will be deployed to all Americans by the end of this year. Pfizer and its partner BioNTech hope to wrap up final-stage Phase III trials of their Covid-19 vaccine candidate as early as next month.

Americans can get COVID-19 vaccine before year-end, says Pfizer CEO

The White House said today that "no one is pressuring the FDA to do anything" after reports said there is increasing pressure on the agency to pass the coronavirus vaccine ahead of the US election to be held on November 3.

No pressure on FDA, says White House on vaccine as US election nears

According to a US newspaper, the US government has urged states to get ready to distribute a potential coronavirus vaccine by November 1. Also Read: AstraZeneca's vaccine has reached Phase 3 clinical trials, says Trump The Wall Street Journal quoting a letter from Robert Redfield, director of the Centers for Disease Control and Prevention, saying: "CDC urgently requests your assistance in expediting applications for these distribution facilities," adding, "if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by Nov.

US states asked to be ready to distribute coronavirus vaccine by November 1: Report